Topics

Life Science Big News Roundup: BriaCell Doses First Patient in Phase I/IIa Study; PreveCeutical Receives AU$616,802 R&D Tax Incentive Cash Refund; Lexaria Provides Update on R&D Program with Altria

13:00 EDT 11 Oct 2019 | Investing News Network

In case you missed it, here is this week’s life science big news roundup.

The post Life Science Big News Roundup: BriaCell Doses First Patient in Phase I/IIa Study; PreveCeutical Receives AU$616,802 R&D Tax Incentive Cash Refund; Lexaria Provides Update on R&D Program with Altria appeared first on Investing News Network.

Original Article: Life Science Big News Roundup: BriaCell Doses First Patient in Phase I/IIa Study; PreveCeutical Receives AU$616,802 R&D Tax Incentive Cash Refund; Lexaria Provides Update on R&D Program with Altria

NEXT ARTICLE

More From BioPortfolio on "Life Science Big News Roundup: BriaCell Doses First Patient in Phase I/IIa Study; PreveCeutical Receives AU$616,802 R&D Tax Incentive Cash Refund; Lexaria Provides Update on R&D Program with Altria"

Quick Search

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...